Psoriasis: consensus on topical therapies. (Q37032806)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18081748%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Psoriasis: consensus on topical therapies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18081748%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18081748%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Christopher Griffiths

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18081748%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

James Mason

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18081748%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Kim A. Papp

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18081748%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

van de Kerkhof PC

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18081748%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Kragballe K

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18081748%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Menter A

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18081748%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

13 December 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18081748%20AND%20SRC:MED&resulttype=core&format=json

Journal of the European Academy of Dermatology and Venereology

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18081748%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18081748%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18081748%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

859-870

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18081748%20AND%20SRC:MED&resulttype=core&format=json

The Salford Psoriasis Index: an holistic measure of psoriasis severity

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02534.X

Current severe psoriasis and the rule of tens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02534.X

Objective assessment of compliance with psoriasis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02534.X

The antipsoriatic compound anthralin influences bioenergetic parameters and redox properties of energy transducing membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02534.X

Topical preparations for the treatment of psoriasis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02534.X

Calcipotriol versus coal tar: a prospective randomized study in stable plaque psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02534.X

Comparison of calcipotriol and coal tar in conjunction with sun exposure in chronic plaque psoriasis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02534.X

Skin cancer in patients with psoriasis treated with coal tar. A 25-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02534.X

Skin carcinoma in patients with psoriasis treated with topical tar and artificial ultraviolet radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02534.X

Effects of glucocorticosteroids on cultured human skin fibroblasts. III. Transient inhibition of cell proliferation in the early growth stages and reduced susceptibility in later growth stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02534.X

Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02534.X

Calcium homeostasis remains unaffected after 12 weeks' therapy with calcitriol 3 microg/g ointment; no correlation with extent of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02534.X

Calcitriol shows greater persistence of treatment effect than betamethasone dipropionate in topical psoriasis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02534.X

Long-term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02534.X

Treatment of scalp psoriasis. An effective and safe tacalcitol emulsion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02534.X

Treatment of psoriasis by the topical application of the novel cholecalciferol analogue calcipotriol (MC 903)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02534.X

Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical tria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02534.X

A new calcipotriol/betamethasone dipropionate formulation (Daivobet) is an effective once-daily treatment for psoriasis vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02534.X

A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02534.X

Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02534.X

Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02534.X

Efficacy of treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol for the treatment of psoriasis vulgaris: a randomised, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02534.X

The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02534.X

Tacrolimus ointment improves psoriasis in a microplaque assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02534.X

An experimental ointment formulation of pimecrolimus is effective in psoriasis without occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02534.X

Topical tacrolimus ointment combined with 6% salicylic acid gel for plaque psoriasis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02534.X

Tacrolimus ointment is effective for facial and intertriginous psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02534.X

Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02534.X

Optimizing the frequency of outpatient short-contact dithranol treatment used in combination with broadband ultraviolet B for psoriasis: a randomized, within-patient controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02534.X

Duration of improvement in psoriasis after treatment with tazarotene 0.1% gel plus clobetasol propionate 0.05% ointment: comparison of maintenance treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02534.X

Strategies to optimize efficacy, duration of remission, and safety in the treatment of plaque psoriasis by using tazarotene in combination with a corticosteroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02534.X

The combination of calcipotriol and methotrexate compared with methotrexate and vehicle in psoriasis: results of a multicentre placebo-controlled randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02534.X

A classification of psoriasis vulgaris according to phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02534.X